- This event has passed.
Successfully navigating the USPTO and FDA
September 8, 2022 @ 1:00 pm - 5:00 pm
Best practices shared to help biotech and medtech startups navigate USPTO and FDA procedures.
About this event
Hear industry professionals and government officials from the United States Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) discuss the intricacies biotech and medtech independent inventors and startups face when securing intellectual property (IP) rights from the USPTO and seeking regulatory approval from the FDA. Space is limited, so register early.Topics:
- Navigating USPTO patent and FDA regulatory processes with an emphasis on biotech and medtech industries
- Initiatives, strategies, tips, and best practices to protect your discoveries and innovations
Speakers:
- Linda Horner, Administrative Patent Judge, Patent Trial and Appeal Board (PTAB), USPTO
- Brandon Fetterolf, Director (acting), TC 1600 Biotechnology and Organic Chemistry, USPTO
- Jonathan Teixeira Moffat, Director, TC 3700 Medical Devices and Processes, USPTO
- Kevin Bugin, Ph.D., Deputy Director for Operations, Office of New Drugs, Center for Drug Evaluation and Research (CDER), FDA
- Barbara Zimmerman, Deputy Office Director, Center for Devices and Radiological Health (CDRH), FDA
- Tom Cowan, Partner, Knobbe Martens
- Kimberly Miller, Partner, Knobbe Martens
*A meeting link will be sent to registered attendees the week of the event.California MCLE credit is available. If you’re not in California, contact your state bar to see how you can obtain credit in your state.For all inquiries, pleaes email siliconvalley@uspto.gov.